Section 174A Is Back

For three years, businesses across the United States have grappled with an unwelcome tax burden. The Tax Cuts and Jobs Act of 2017 forced companies to capitalize and amortize their domestic research and experimental expenditures over five years—a dramatic departure from decades of immediate expensing that had fueled American innovation. That era is over.